Marks & Spencer has launched a pioneering new line of meals and snacks, specifically formulated to support the growing number of Britons using weight-loss injections. The retailer's 'Nutrient Dense' collection aims to help customers meet vital nutritional targets even when their appetite is suppressed by medications like Wegovy and Mounjaro.
Addressing a Nutritional Gap
The range, which launches in M&S Foodhalls on 5 January, features 20 products designed to pack fibre, vitamins, and minerals into every bite. This initiative responds to concerning data from the government's National Diet and Nutrition Survey 2025, which found that 96% of the UK population fails to meet the daily fibre recommendation.
Annette Peters, M&S Head of Food Trends, explained the thinking behind the launch. "We know the use of GLP-1 medications is growing," she said. "It's more important than ever to ensure that even if people are eating smaller portions, we help provide them with the right level of nutrients."
What's in the Range?
The collection is diverse, catering to different needs throughout the day. It includes prepared salads, ready meals, and a 'Super Seeded Oaty Bread'. Notable drink options feature a scientifically-backed H5O shot, developed with botanists from the Royal Botanic Gardens, Kew, alongside coconut water and cold-pressed ginger juice. Supplements like fruit and vegetable fibre and sea moss complete the offering.
Nutrient-dense foods are defined by providing a high concentration of vitamins, minerals, and other beneficial components relative to their calorie content, making them ideal for those consuming less food overall.
Surge in Private Drug Use
M&S's strategic move aligns with a dramatic surge in the use of GLP-1 agonist drugs. According to figures from life science analytics firm IQVIA, obtained by the Telegraph, 2.49 million packs of Mounjaro and Wegovy were purchased in July 2025. This represents a staggering increase from just 493,000 packs in the same month the previous year.
Sales reportedly jumped by another million between July and August, though this was partly attributed to stockpiling ahead of a September price hike. Crucially, it is estimated that around 90% of people using these weight-loss jabs are currently funding them privately, via online services and high street pharmacies.
While the NHS has begun its roll-out of Mounjaro, eligibility criteria remain strict. The health service expects to provide the injections to approximately 240,000 people over a three-year period, leaving a significant market of private users whom retailers like M&S are now actively targeting with tailored products.
